title: Baicalein preconditioning protects cardiomyocytes from ischemia-reperfusion injury via mitochondrial oxidant signaling.
abstract: Previous studies suggest baicalein, in addition to its antioxidant effects, protects against hypoxia/reoxygenation injury via its pro-oxidant properties. We hypothesize that a brief period of baicalein treatment prior to ischemia/reperfusion (I/R) may trigger preconditioning protection via a mitochondrial pro-oxidant mechanism. Using an established chick cardiomyocyte model of I/R, cells were preconditioned with baicalein (10 μM) for 10 min followed by 10-min wash prior to I/R. Intracellular oxidants were measured using 2', 7'-dichlorofluorescin diacetate (DCFH/DA). Cell viability was assessed by propidium iodide and apoptosis determined by DNA fragmentation. Baicalein induced a transient but significant increase of DCF fluorescence within the 10-min preconditioning period, and led to significant reduction of cell death (38.9 ± 1.8% vs. 58.7 ± 1.2% in I/R control, n = 6, p < 0.001) and DNA fragmentation after I/R. Cotreatment with N-acetylcysteine (500 μM), mitochondrial complex III electron transport chain inhibitor myxothiazol (1 μM), mitochondrial KATP channel blocker 5-hydroxydecanoate-Na (5-HD, 500 μM) or anion channel inhibitor 4', 4'-diisothiocyanato-stilbene-2, 2'-disulfonic acid (DIDS, 200 μM) resulted in significant abrogation of oxidant increase during induction as well as the protection conferred by baicalein preconditioning. These results suggest that baicalein preconditioning exhibits significant anti-apoptotic protection against cardiomyocyte I/R injury by mitochondrial oxidant signaling, which was in part mediated by mitochondrial KATP channel and anion channel opening.
authors.affiliation: Department of Emergency Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
authors.forename: Wei-Tien
authors.initials: WT
authors.lastname: Chang
authors.forename: Jing
authors.initials: J
authors.lastname: Li
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Vanden Hoek
authors.forename: Xiangdong
authors.initials: X
authors.lastname: Zhu
authors.forename: Chang-Qing
authors.initials: CQ
authors.lastname: Li
authors.forename: Hsien-Hao
authors.initials: HH
authors.lastname: Huang
authors.forename: Chin-Wang
authors.initials: CW
authors.lastname: Hsu
authors.forename: Qiang
authors.initials: Q
authors.lastname: Zhong
authors.forename: Juan
authors.initials: J
authors.lastname: Li
authors.forename: Sy-Jou
authors.initials: SJ
authors.lastname: Chen
authors.forename: Terry L
authors.initials: TL
authors.lastname: Vanden Hoek
authors.forename: Zuo-Hui
authors.initials: ZH
authors.lastname: Shao
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D002642:Chick Embryo; D044950:Flavanones / Q000008:administration & dosage*; D006801:Humans; D019194:Ischemic Preconditioning; D008929:Mitochondria, Heart / Q000187:drug effects / Q000378:metabolism*; D032383:Myocytes, Cardiac / Q000187:drug effects* / Q000378:metabolism; D016877:Oxidants / Q000378:metabolism*; D015427:Reperfusion Injury / Q000188:drug therapy / Q000378:metabolism* / Q000517:prevention & control*; D015398:Signal Transduction
chemical_list: D044950:Flavanones; D016877:Oxidants; C006680:baicalein